Gilead buys CAR-T developer Kite Pharma for $12BAugust 29, 2017Gilead Sciences CEO John Milligan, under pressure from a flagging… https://cancure.com/wp-content/uploads/2015/05/Cancure_Logo_Website_v01.png 0 0 admin https://cancure.com/wp-content/uploads/2015/05/Cancure_Logo_Website_v01.png admin2017-08-29 08:58:062017-11-01 09:35:19Gilead buys CAR-T developer Kite Pharma for $12B
